Feb 18, 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Jan 25, 2021
OncoSec Medical Closes $42.0 Million Public Offering of Common Stock
Jan 20, 2021
OncoSec Medical Announces Proposed Public Offering of Common Stock
Jan 19, 2021
OncoSec Enters into Option Agreement with Sirtex Medical to Co-Promote TAVO(TM)
Jan 08, 2021
OncoSec Announces First Patient Dosed in Phase 2 Trial of TAVO(TM) Plus OPDIVO® as Neoadjuvant Therapy for Melanoma
Dec 10, 2020
OncoSec Strengthens IP Portfolio with Allowance of Two European Patent Applications Covering TAVO(TM) and Its Gene Electrotransfer Technology
Nov 24, 2020
OncoSec Announces Exclusive License Agreement for Cliniporator® Gene Electrotransfer Platform Developed by IGEA Clinical Biophysics
Nov 05, 2020
OncoSec Hosting an Investor and Analyst Day Webinar Showcasing Positive KEYNOTE-695 Data in Anti-PD-1 Checkpoint Refractory Metastatic Melanoma
Nov 03, 2020
OncoSec to Present Positive Interim Data from KEYNOTE-695 Trial in Anti-PD-1 Checkpoint Refractory Metastatic Melanoma at SITC 2020
Oct 29, 2020
OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19
Oct 12, 2020
OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
Oct 06, 2020
OncoSec Announces Issuance of New U.S. Patent Expanding Coverage of TAVO(TM) and Its Gene Delivery Platform
Aug 27, 2020
OncoSec Announces Initiation of a Phase 2 Study at the Moffitt Cancer Center to Evaluate the Combination of TAVO plus OPDIVO® as Neoadjuvant Therapy for Melanoma
Aug 25, 2020
OncoSec to Present at the LD 500 Virtual Conference on September 2, 2020
Aug 16, 2020
OncoSec Medical Incorporated Announces Pricing of Public Offering
Aug 14, 2020
OncoSec Medical Incorporated Announces Proposed Public Offering of Common Stock
Jul 27, 2020
OncoSec Appoints Kellie Malloy Foerter as Chief Operating Officer
Jul 13, 2020
OncoSec's Novel COVID-19 Vaccine Candidate Featured in 'Straight Talk' Program by NBC TV in Portland, Oregon
Jun 24, 2020
OncoSec Set to Join Russel Microcap® Index
Jun 22, 2020
OncoSec Presents Two Late-Breaking Abstracts on TAVO-PLUS at the American Association for Cancer Research (AACR) Virtual Annual Meeting II